May 18, 2018
125th Anniversary / Neuroscience / Video
Cancer
A Phase Two clinical trial led by Dr. Jennifer Connelly examines the potential of an oral medication to treat this aggressive cancer.
Basic Science
Dr. Tayler Sheahan leads innovative studies that may lead to better therapies for these conditions.
Neuroscience
Dr. Brian Lin is at the forefront of a promising approach to treat Duchenne muscular dystrophy.